Azelastine EP Impurity A(CAS: 613-94-5)

Azelastine EP Impurity A (CAS: 613-94-5) is a chemical compound identified as an impurity in the pharmaceutical drug Azelastine. It is a derivative of the parent molecule, typically formed during synthesis or degradation processes. The compound exhibits specific structural and chemical properties, making it relevant for pharmaceutical quality control and research. Its molecular formula is C17H20N2O2, and it is characterized by its use in analytical testing to ensure drug purity and compliance with regulatory standards.

Azelastine EP Impurity A (CAS: 613-94-5) is primarily used in pharmaceutical research and development for identifying and quantifying impurities in Azelastine medications. It also plays a role in analytical methods to assess drug stability and ensure adherence to pharmacopeial standards. Additionally, it may be utilized in industrial settings for chemical synthesis studies or as a reference standard in quality assurance processes for drug manufacturing.

Azelastine EP Impurity A (CAS: 613-94-5) is generally considered safe in controlled amounts, but proper handling is essential. As an impurity, it may have lower toxicity compared to the active compound Azelastine, yet it should still be treated with caution. Safety protocols include wearing gloves, safety goggles, and ensuring adequate ventilation during handling. Regulatory guidelines from ICH and EPA emphasize minimizing exposure and following standard chemical safety practices to ensure workplace and environmental safety.

Azelastine EP Impurity A (CAS: 613-94-5) should be stored in a cool, dry place, away from light, in tightly sealed amber glass containers. It is stable under these conditions but may degrade if exposed to high temperatures or humidity. Proper storage ensures chemical integrity and prevents contamination. Maintain storage conditions as per ICH guidelines to preserve its quality for analytical or research purposes.